Inside-Filings
Projekt anfragen

Zeo ScientifiX, Inc. (ZEOX)

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
28.01.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECr” refer to Zeo ScientifiX, Inc.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointm
05.01.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECd “our” refer to Zeo ScientifiX, Inc.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App
03.12.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECd “our” refer to Zeo ScientifiX, Inc.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App
21.07.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECd “our” refer to Zeo ScientifiX, Inc.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App
12.05.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECforded by Section 4(a)(2) thereof.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoin
02.04.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECd “our” refer to Zeo ScientifiX, Inc.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App
10.02.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECll govern the terms of the Joint Venture.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
07.08.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECAct afforded by Section 4(a)(2) thereof.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
03.06.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECr” refer to Zeo ScientifiX, Inc.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointm
02.04.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECr” refer to Zeo ScientifiX, Inc.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointm
11.07.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECicine, Inc., and its subsidiaries.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoin
15.05.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECicine, Inc., and its subsidiaries.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoin
01.05.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECicine, Inc., and its subsidiaries.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appoin

Stammdaten

Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. The company's lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, and knee osteoarthritis. It also provides Patient Pure X, an autologous blood-derived biologic technology, that helps the body's natural ability to decrease cellular inflammation and promote tissue healing. In addition, the company develops and distributes products that incorporate its proprietary ingredients for products to be used in topical aesthetic applications; ZEO GROW X, a professional-grade formula that delivers a concentrated dose of topical exosomes that help support follicular function; ZEO GROW BOOST; and EXO FOLLICLE FUEL. The company was formerly known as Organicell Regenerative Medicine, Inc. and changed its name to Zeo ScientifiX, Inc. in February 2024. Zeo ScientifiX, Inc. was incorporated in 2011 and is headquartered in Davie, Florida.

Unternehmen & Branche

NameZeo ScientifiX, Inc.
TickerZEOX
CIK0001557376
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2836 · Biological Products, (No Diagnostic Substances)

Wertpapier & Kennzahlen

CUSIP68621D206
ISINUS68621D2062
TypCommon Stock
Marktkapitalisierung11,8 Mio. USD
Beta3,92
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2026-01-3110-Q1,446,000-852,000-0.122,571,000-383,000
2025-10-3110-K5,199,000-5,521,000-0.861,527,000-1,423,000
2025-07-3110-Q1,306,000-2,072,000-0.321,652,000-2,314,000
2025-04-3010-Q1,149,000-1,391,000-0.221,435,000-2,100,000
2025-01-3110-Q1,090,000-1,243,000-0.201,550,000-1,805,000
2024-10-3110-K4,620,000-4,705,000-0.741,643,000-1,653,000
2024-07-3110-Q1,091,000-1,012,000-0.162,221,000-1,422,000
2024-04-3010-Q1,131,000-1,399,000-0.231,932,000-1,700,000
2024-01-3110-Q1,154,000-1,040,000-0.172,432,000-1,508,000
2023-10-3110-K4,558,000-6,987,000-0.992,782,000-1,241,000
2023-07-3110-Q1,221,000-1,618,000-0.232,455,661-1,022,000
2023-04-3010-Q845,000-1,991,000-0.273,334,584-139,000
2023-01-3110-Q1,070,000-2,287,000-0.334,317,796677,000
2022-10-3110-K6,491,008-8,896,557-1.566,200,6881,889,000
2022-07-3110-Q1,713,214-2,727,4570.002,557,799-4,611,812
2022-04-3010-Q1,735,173-1,456,0432,214,972-4,190,090
2022-01-3110-Q1,599,147-1,693,7362,079,133-3,287,439
2021-10-3110-K5,597,487-12,756,5601,932,957-2,665,593
2021-07-3110-Q1,367,895-1,408,9081,716,188-2,463,357
2021-04-3010-Q1,195,076-2,239,4951,308,167-2,518,453

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2025-06-25Skycrest Holdings, LLCOpen Market Purchase6,0002.0012,000.00+106,6%
2025-06-20Skycrest Holdings, LLCOpen Market Purchase1,0022.272,274.54+20,2%
2025-06-18Skycrest Holdings, LLCOpen Market Purchase3,0002.056,150.00+54,6%
2025-06-11Skycrest Holdings, LLCOpen Market Purchase5242.001,048.00+9,3%
2025-06-09Skycrest Holdings, LLCOpen Market Purchase1381.99274.62+2,4%
2025-06-06Skycrest Holdings, LLCOpen Market Purchase11,1002.0022,200.00+197,1%
2025-05-23Skycrest Holdings, LLCOpen Market Purchase5001.92960.00+8,5%
2025-05-21Skycrest Holdings, LLCOpen Market Purchase1,0002.102,100.00+18,6%
2025-05-21Skycrest Holdings, LLCOpen Market Purchase2,0002.074,140.00+36,8%
2025-05-12Skycrest Holdings, LLCOpen Market Purchase8682.652,300.20+20,4%
2025-05-09Skycrest Holdings, LLCOpen Market Purchase1,0542.662,803.64+24,9%
2025-05-08Skycrest Holdings, LLCOpen Market Purchase5,0002.7513,750.00+122,1%
2025-05-08Skycrest Holdings, LLCOpen Market Purchase2,5782.656,831.70+60,7%
2025-05-08Skycrest Holdings, LLCOpen Market Purchase5,0002.8114,050.00+124,8%
2025-05-07Skycrest Holdings, LLCOpen Market Purchase14,4593.0844,533.72+395,4%
2025-05-06Skycrest Holdings, LLCOpen Market Purchase5002.981,490.00+13,2%
2025-05-06Skycrest Holdings, LLCOpen Market Purchase1,0003.323,320.00+29,5%
2025-05-06Skycrest Holdings, LLCOpen Market Purchase5003.271,635.00+14,5%
2025-05-05Skycrest Holdings, LLCOpen Market Purchase30,5002.8887,840.00+780,0%
2025-05-01Skycrest Holdings, LLCOpen Market Purchase2,4002.004,800.00+42,6%
2025-04-30Skycrest Holdings, LLCOpen Market Purchase9492.101,992.90+17,7%

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×